Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease (Q37917111)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 1990

edit

Language	Label	Description	Also known as
English	Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease	scientific article published on March 1990

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2184010

retrieved

25 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2184010

retrieved

25 August 2017

main subject

pharmacology

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

Langtry HD

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2184010

retrieved

25 August 2017

Clissold SP

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2184010

retrieved

25 August 2017

language of work or name

English

1 reference

based on heuristic

inferred from title

publication date

1 March 1990

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2184010

retrieved

25 August 2017

published in

Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2184010

retrieved

25 August 2017

volume

39

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2184010

retrieved

25 August 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2184010

retrieved

25 August 2017

page(s)

491-506

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2184010

retrieved

25 August 2017

cites work

Parkinsonism: onset, progression, and mortality

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term study of pergolide in Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term experience with pergolide therapy of advanced parkinsonism

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide in late-stage Parkinson disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parallel double-blind study of pergolide in Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide therapy in Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of pergolide and mesulergine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinities in vitro

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potent 48 hours inhibition of prolactin secretion by pergolide in hyperprolactinaemic women

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopaminergic inhibition of cardiac sympathetic nerve function by pergolide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide for the treatment of pituitary tumors secreting prolactin or growth hormone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide mesylate: a potent day-long inhibitor of prolactin in rhesus monkeys and patients with Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind assessment of potential pergolide-induced cardiotoxicity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Q64764700

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide therapy in Parkinson's disease: a double-blind, placebo-controlled study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind trial of pergolide for Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythromelalgia following pergolide administration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hallucinations and confusion after pergolide withdrawal

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide: long-term use in Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac effects of pergolide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide in the treatment of Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Further characterization of tolerance to the corticosterone-elevating effect of pergolide in rats

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind controlled study of pergolide mesylate in the treatment of Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Q64774364

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Domperidone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year trial of pergolide as an adjunct to Sinemet in treatment of Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hyperprolactinaemic patients with pergolide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide therapy for Parkinson's disease: neurobehavioral changes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide mesylate inhibits exercise-induced prolactin release in man.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Q64764609

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine t

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiologic disposition of pergolide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine agonist-induced hyperglycemia in rats: Structure-activity relationships and mechanisms of action

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agent

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical study of pergolide in Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide and lisuride in advanced Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide mesylate: its effects on circulating anterior pituitary hormones in man

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy of pergolide in patients with Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced Parkinson disease with pergolide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of pergolide with central dopaminergic receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide in the treatment of Parkinson's disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha-2-adrenoceptor-mediated effects of pergolide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lisuride, a dopamine agonist in the treatment of early Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide in Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide, a potent long-acting dopamine-receptor agonist

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide and bromocriptine for the treatment of patients with hyperprolactinemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of Insulin Release from Rat Pancreatic Islets by Drugs that Are Analogues of Dopamine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Q64762166

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevation of Serum Corticosterone Concentrations in Rats by Pergolide and Other Dopamine Agonists

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide mesylate and idiopathic Parkinson disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of a single oral dose of pergolide on intraocular pressure and pupil diameter

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine agonists as primary treatment in Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide mesylate: lack of cardiac toxicity in patients with cardiac disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Parkinson's disease with pergolide: a double-blind study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amphetamine discrimination: effects of dopamine receptor agonists

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy of two dopamine agonists, pergolide and lergotrile, in Parkinson disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of adenylate cyclase in rat striatum by an ergoline dopamine agonist, pergolide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopa dose-dependent sexual deviation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of pergolide mesylate in long term treatment of hyperprolactinaemia.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Q64816463

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of pergolide, a potent dopamine agonist, in Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Q64784989

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesulergine and pergolide in previously untreated Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brain

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2184010

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00003495-199039030-00009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2184010

retrieved

25 August 2017

Dimensions Publication ID

1045717728

0 references

PubMed publication ID

2184010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2184010

retrieved

25 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37917111&oldid=2201077650"